AU Patent

AU2014259534B2 — Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (AMD)

Assigned to Novartis AG · Expires 2016-05-19 · 10y expired

What this patent protects

H:\re\tevoven\NRPoH C1b]\CCC6950532 _ docx:-6/ 1/ 2611 The present invention provides a compound of formula 1: x 2 xK R20 N G (C R21R22)g-Z G' z7 / Z - ,Z4 Z Z R3 (I) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention furthe…

USPTO Abstract

H:\re\tevoven\NRPoH C1b]\CCC6950532 _ docx:-6/ 1/ 2611 The present invention provides a compound of formula 1: x 2 xK R20 N G (C R21R22)g-Z G' z7 / Z - ,Z4 Z Z R3 (I) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014259534B2
Jurisdiction
AU
Classification
—
Expires
2016-05-19
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.